accounton Friday, while King's shares were off 12 cents, to $9.76. The back and forth between the two pharmaceutical companies is similar to the push- pull that has been going on between Bristol-Myers Squibb (nyse: BMY - news - people ) and Carl Icahn's ImClone...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Alpharma Turns Down King--Again
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account